Meena S, Kosgei B, Soko G, Tingjun C, Chambuso R, Mwaiselage J
NPJ Vaccines. 2025; 10(1):18.
PMID: 39870669
PMC: 11772600.
DOI: 10.1038/s41541-024-01035-3.
Hwang H, Kim J, Kim T, Han Y, Choi D, Cho S
BMC Cancer. 2024; 24(1):1557.
PMID: 39702014
PMC: 11660897.
DOI: 10.1186/s12885-024-13342-y.
Xiao Y, Tao P, Zhang K, Chen L, Lv J, Chen Z
Mol Cancer. 2024; 23(1):262.
PMID: 39574133
PMC: 11580229.
DOI: 10.1186/s12943-024-02170-0.
Mir R, Baba S, Elfaki I, Algehainy N, Alanazi M, Altemani F
J Cancer. 2024; 15(19):6383-6415.
PMID: 39513123
PMC: 11540496.
DOI: 10.7150/jca.98426.
Jin X, Lin T, Wang Y, Li X, Yang Y
Front Mol Biosci. 2024; 11:1486576.
PMID: 39498333
PMC: 11532153.
DOI: 10.3389/fmolb.2024.1486576.
Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells.
Rabas N, Ferreira R, Di Blasio S, Malanchi I
Nat Rev Cancer. 2024; 24(12):829-849.
PMID: 39390247
DOI: 10.1038/s41568-024-00752-0.
Sialyl Lewis X decorated integrin α3 on small extracellular vesicles promotes metastasis of bladder cancer via enhancing vascular permeability.
Feng H, Liang L, Deng W, Gao J, Li X, Guan F
Angiogenesis. 2024; 27(4):883-901.
PMID: 39222273
DOI: 10.1007/s10456-024-09947-3.
Exosomal miRNAs: the tumor's trojan horse in selective metastasis.
Bayat M, Nahand J
Mol Cancer. 2024; 23(1):167.
PMID: 39164756
PMC: 11334467.
DOI: 10.1186/s12943-024-02081-0.
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside.
Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S
Exp Hematol Oncol. 2024; 13(1):72.
PMID: 39085965
PMC: 11292955.
DOI: 10.1186/s40164-024-00539-x.
MiR-30c suppresses the proliferation, metastasis and polarity reversal of tumor cell clusters by targeting MTDH in invasive micropapillary carcinoma of the breast.
Han Y, Li W, Zhi R, Ma G, Gao A, Wu K
Heliyon. 2024; 10(13):e33938.
PMID: 39071710
PMC: 11279262.
DOI: 10.1016/j.heliyon.2024.e33938.
Exosomal microRNAs: impact on cancer detection, treatment, and monitoring.
Kumar R
Clin Transl Oncol. 2024; 27(1):83-94.
PMID: 38971914
DOI: 10.1007/s12094-024-03590-6.
Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma.
Xu J, Zhao Y, Chen Z, Wei L
J Pers Med. 2024; 14(4).
PMID: 38673047
PMC: 11051574.
DOI: 10.3390/jpm14040420.
NSCLC Extracellular Vesicles Containing miR-374a-5p Promote Leptomeningeal Metastasis by Influencing Blood‒Brain Barrier Permeability.
Jin J, Cui Y, Niu H, Lin Y, Wu X, Qi X
Mol Cancer Res. 2024; 22(8):699-710.
PMID: 38639925
PMC: 11294816.
DOI: 10.1158/1541-7786.MCR-24-0052.
Extracellular vesicle-mediated pre-metastatic niche formation via altering host microenvironments.
Li Y, Zheng Y, Tan X, Du Y, Wei Y, Liu S
Front Immunol. 2024; 15:1367373.
PMID: 38495881
PMC: 10940351.
DOI: 10.3389/fimmu.2024.1367373.
Clinical significance of exosomal noncoding RNAs in hepatocellular carcinoma: a narrative review.
Yoo J, Kang M
J Yeungnam Med Sci. 2024; 42:4.
PMID: 38325815
PMC: 11812098.
DOI: 10.12701/jyms.2023.01186.
Exosomal miR-3174 induced by hypoxia promotes angiogenesis and metastasis of hepatocellular carcinoma by inhibiting HIPK3.
Yang X, Wu M, Kong X, Wang Y, Hu C, Zhu D
iScience. 2024; 27(2):108955.
PMID: 38322996
PMC: 10845063.
DOI: 10.1016/j.isci.2024.108955.
[Hepatocellular Carcinoma-Derived Exosomes: Key Players in Intercellular Communication Within the Tumor Microenvironment].
Feng T, Yang X, Wang Q, Liu X
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(1):6-12.
PMID: 38322525
PMC: 10839483.
DOI: 10.12182/20240160203.
Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application.
Yang Q, Li S, Ou H, Zhang Y, Zhu G, Li S
J Nanobiotechnology. 2024; 22(1):41.
PMID: 38281957
PMC: 10823703.
DOI: 10.1186/s12951-024-02298-7.
Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD.
Kim S, Hyun J
Mol Cells. 2024; 47(2):100010.
PMID: 38237744
PMC: 10960132.
DOI: 10.1016/j.mocell.2024.100010.
New insights into the correlations between circulating tumor cells and target organ metastasis.
Zhan Q, Liu B, Situ X, Luo Y, Fu T, Wang Y
Signal Transduct Target Ther. 2023; 8(1):465.
PMID: 38129401
PMC: 10739776.
DOI: 10.1038/s41392-023-01725-9.
